Palmitoylethanolamide (PEA)

Bioavailability Optimization Features

Palmitoylethanolamide (PEA) belongs to the fatty acid ethanolamide family and features a naturally lipophilic structure. This molecular structure facilitates its dispersion and absorption in lipid environments. To meet oral application requirements, AIDU Biotech utilizes particle size control technology to increase the specific surface area, thereby optimizing gastrointestinal dispersion, making it suitable for formulation systems related to neurological health and inflammation regulation.

AIDU Biotech employs physical modification technology to offer the following three core specifications:Regular PEA: 100% passes through a 40-mesh sieve, suitable for basic formulations and cost-sensitive bulk applications.Micronized PEA: The particle size is precisely controlled at D(0.80∼1.00) 10 μm. With an ultra-large specific surface area, it accelerates dissolution and absorption in the gastrointestinal tract, significantly enhancing bioavailability.Liposomal PEA: Available with core content levels of 50% and 70%, it leverages lipid encapsulation technology to mimic biological membrane structures, achieving optimal transmembrane transport efficiency.

High-Purity Control Process

Adopting controlled amidation reactions and multi-stage purification processes, combined with recrystallization and impurity profile management, we conduct full-process monitoring of key quality attributes (assay, related substances, residual solvents, and heavy metals). The finished product maintains a stable purity of ≥98%, ensuring batch consistency and long-term supply stability, thus meeting the stringent quality requirements for raw materials in the high-end dietary supplement and medical nutrition sectors.

Quality System and Compliant Production

Products are manufactured at scale in our own production bases, with the production system complying with cGMP quality management standards. We implement comprehensive raw material traceability and release standards, covering physicochemical index testing, microbial control, heavy metal testing, and stability assessment. The products meet quality standards such as Non-GMO, Solvent-free, and Gluten-free, providing robust support for compliant applications in the US and EU markets.

Stable Supply and Global Delivery Capability

Backed by mature industrialized production capabilities and a sound supply chain management system, we can ensure a stable supply of bulk raw materials. By integrating localized warehousing resources with an international logistics system, we achieve efficient delivery and inventory assurance, meeting the long-term strategic cooperation needs of OEM/ODM clients and brand owners.

Neuro Support & Comfort Balance

Palmitoylethanolamide (PEA) is widely incorporated into formulations designed to support neuroimmune balance and nervous system homeostasis. By modulating inflammatory signaling pathways and cellular stress responses, it provides comprehensive comfort support for conditions associated with prolonged physiological stress.

Healthy Inflammatory Response Support

PEA participates in the regulation of pro-inflammatory mediator signaling. Leveraging the PPAR-α-dependent pathway, it helps maintain a balanced inflammatory response and cellular oxidative stability.

Immune & Mast Cell Modulation

Backed by the well-validated ALIA (Autacoid Local Injury Antagonism) mechanism, PEA effectively regulates mast cell reactivity, thereby safeguarding immune equilibrium and tissue comfort when facing environmental or physiological stressors.

Neuroprotection & Mitochondrial Support

PEA helps stabilize mitochondrial membrane integrity and ensures the normal operation of cellular energy metabolism under inflammatory conditions. By reducing oxidative stress signaling, it enhances neuronal resilience and maintains metabolic balance.

Scientific Research & Data Backing

A. PPAR-α Signaling Pathway ModulationPalmitoylethanolamide (PEA) is recognized as an endogenous ligand of Peroxisome Proliferator-Activated Receptor-α (PPAR-α). PPAR-α belongs to the nuclear receptor superfamily and is involved in the transcriptional regulation of inflammatory signals as well as the maintenance of lipid metabolic balance.Upon binding to the receptor, the activation of PPAR-α can regulate the transcriptional activities of genes related to cytokine expression and oxidative stress balance, thereby modulating the dynamic changes of inflammatory signaling pathways.Literature References:Verme et al., 2005 – Demonstrated that the biological activity of PEA relies on the PPAR-α pathway,Molecular Pharmacology,DOI: 10.1124/mol.104.010439;D’Agostino et al., 2007 – Reported that PEA participates in the regulation of inflammatory signals via PPAR-α,European Journal of Pharmacology*,DOI: 10.1016/j.ejphar.2007.07.024

B. Mast Cell Modulation – ALIA MechanismPEA possesses the classic Autacoid Local Injury Antagonism (ALIA) effect, the core of which lies in the precise regulation of mast cell reactivity.Mast cells play a key role in tissue inflammation and the crosstalk between neuro-immune signals. Studies have confirmed that PEA can effectively intervene in the activation and degranulation processes of mast cells, thus providing solid support for maintaining local tissue homeostasis under physiological stress conditions.Literature References:Aloe et al., 1993 – First proposed the regulatory effect of PEA on mast cells,Agents and Actions,DOI: 10.1007/BF01972767;Levi-Montalcini et al., 1996 – Explained the theoretical basis of ALIA,NeuroReport*,DOI: 10.1097/00001756-199610020-00027

C. Mitochondrial Support & Synergy MechanismPEA participates in the regulation of cellular lipid signaling networks, and its roles in the following aspects have been reported in studies:

Maintaining the stability of mitochondrial membrane potential

Regulating inflammation-related reactive oxygen species (ROS) signals

Supporting the maintenance of cellular energy metabolic homeostasisIn addition, PEA is believed to indirectly act on the endocannabinoid system by regulating the levels of endogenous lipid mediators. This synergistic mechanism is referred to as the "Entourage Effect".Literature References:Petrosino & Di Marzo, 2017 – Reviewed the relationship between PEA and the endocannabinoid system,British Journal of Pharmacology,DOI: 10.1111/bph.13627;Skaper et al., 2015 – Reviewed the molecular mechanism of PEA in the regulation of neuroinflammation,CNS & Neurological Disorders – Drug Targets,DOI: 10.2174/1871527314666150821102842*The listed references are for scientific and mechanistic discussion purposes only. This ingredient is not intended to diagnose, treat, cure, or prevent any disease.